FREMONT, Calif., Feb. 28, 2011 /PRNewswire/ — WaferGen
Biosystems, Inc. (OTC Bulletin Board:
WGBS), a leading developer of state-of-the-art genomic analysis
systems, today announced that industry leader Dr. Timothy J.
Triche, Professor of Pathology and Pediatrics at the University of
Southern California (USC) Keck School of Medicine, has joined the
Board of Directors of WaferGen.
“Dr. Triche joined our Scientific Advisory Board in December,
and we discovered quickly that he brings valuable leadership
experience to WaferGen from a distinguished medical and research
career. His vast know-how in using genomic technologies
include Next Generation Sequencing (NGS), microarrays and real-time
PCR in the clinical research and diagnostics markets that will help
WaferGen broaden our reach into these high-growth markets,” said
Alnoor Shivji, Chairman and CEO, WaferGen. “He comprehends how our
SmartChip System can make a major contribution to the genomics
analysis field, and also has broad experience at cancer genomics
research specifically.”
Dr. Triche reiterated, “I believe that the new SmartChip System
can help fill a key need in the world of genomic medicine and guide
the use of targeted medicines to treat patient populations likely
to respond to these agents by greatly enhancing the validation of
gene expression patterns (biomarkers). In particular, a vast
amount of existing genomic discovery research will require an
inexpensive, proven platform like WaferGen’s to achieve clinical
acceptance and utility. I look forward to continuing to work
with WaferGen and the management team in my capacity as a board
member, and to advancing the company and its genomics analysis
products to assure that it can contribute to the specific needs of
patients.”
Dr. Triche fills the vacancy on the board resulting from the
departure of Nadine Smith from the board on Febr
‘/>”/>
SOURCE
